Your browser doesn't support javascript.
loading
Intraventricular melanocytoma diagnosis confirmed by gene mutation profile.
Knappe, Ulrich J; Tischoff, Iris; Tannapfel, Andrea; Reinbold, Wolf-Dieter; Möller, Inga; Sucker, Antje; Schadendorf, Dirk; Griewank, Klaus G; van de Nes, Johannes A P.
Afiliación
  • Knappe UJ; Department of Neurosurgery, Ruhr University Bochum, Johannes Wesling Hospital Minden, Minden, Germany.
  • Tischoff I; Institute of Pathology, Ruhr University Bochum, Bochum, Germany.
  • Tannapfel A; Institute of Pathology, Ruhr University Bochum, Bochum, Germany.
  • Reinbold WD; Department of Radiology, Ruhr University Bochum, Johannes Wesling Hospital Minden, Minden, Germany.
  • Möller I; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen, Germany.
  • Sucker A; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen, Germany.
  • Griewank KG; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen, Germany.
  • van de Nes JAP; Dermatopathologie bei Mainz, Nieder-Olm, Germany.
Neuropathology ; 38(3): 288-292, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29226425
Primary leptomeningeal melanocytic tumors (PLMTs) are rare. They usually arise along the spinal cord and at the skull base. Here we report on a patient with a very rare intraventricular melanocytoma. Histologically, a melanocytic tumor was clearly diagnosed. However, to make the uncommon diagnosis of an intraventricular melanocytoma, metastatic melanoma needed to be excluded. Next generation sequencing covering gene mutations that may occur in PLMTs and cutaneous melanoma was performed. The unique gene mutation profile detected, consisting of an activating CYSLTR2 L129Q mutation and EIF1AX G9R mutation and a lack of mutations in genes known to occur in metastatic melanoma (i.e. BRAF or NRAS) confirmed the diagnosis of an intraventricular melanocytoma. This case report is the second intraventricular melanocytoma published to date and demonstrates the value of applying novel genetic assays to make this diagnosis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Ventrículo Cerebral / Melanocitos / Neoplasias Meníngeas Tipo de estudio: Diagnostic_studies Límite: Aged80 / Humans / Male Idioma: En Revista: Neuropathology Asunto de la revista: NEUROLOGIA / PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Ventrículo Cerebral / Melanocitos / Neoplasias Meníngeas Tipo de estudio: Diagnostic_studies Límite: Aged80 / Humans / Male Idioma: En Revista: Neuropathology Asunto de la revista: NEUROLOGIA / PATOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Alemania